Softgel KOVIR (TD0068)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Softgel KOVIR (TD0068), covering 2022-02-07 to 2022-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Softgel KOVIR (TD0068) in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) [Phase 2]